NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma

Mukherjee, S; Hurt, CN; Gwynne, S; Bateman, A; Gollins, S; Radhakrishna, G; Hawkins, M; ... Crosby, T; + view all Mukherjee, S; Hurt, CN; Gwynne, S; Bateman, A; Gollins, S; Radhakrishna, G; Hawkins, M; Canham, J; Lewis, W; Grabsch, HI; Sharma, RA; Wade, W; Maggs, R; Tranter, B; Roberts, A; Sebag-Montefiore, D; Maughan, T; Griffiths, G; Crosby, T; - view fewer (2015) NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer , 15 , Article 48. 10.1186/s12885-015-1062-y . Green open access

http://ift.tt/2il6ABc